amylin analogue
Cagrilintide
Answer
Cagrilintide is not authorised on any of the 10 registers read, and 1 of them holds no reading for it. Highest trial phase: Phase 3 (17 phase 3 trials, 0 with posted results). It has 66 registered trials, 17 of them running.
RegulatorTrial register10 regulators' registers, read 2026-08-31 to 2026-10-03 · ClinicalTrials.gov and EU CTIS, read 2026-10-03
Not medical, legal or regulatory advice.
66 trials by status
Trial registerClinicalTrials.gov and EU CTIS · read 2026-10-03 · 1 trials have posted results
Trials first submitted per year
Trial registerClinicalTrials.gov first-submitted date, last 6 years · read 2026-10-03. 2026 is not complete. 23 trials carry no first-submitted date (EU CTIS publishes none, or the year is outside this range).
Status by jurisdiction
World map| Where | Status | Register | Read |
|---|---|---|---|
| United States | Not on the register | FDA, openfda | 2026-10-03 |
| European Union | Not on the register | EMA, ema | 2026-08-31 |
| United Kingdom | Not on the register | MHRA, uk-mhra | 2026-09-03 |
| Canada | Not on the register | Health Canada, ca-dpd | 2026-09-03 |
| Australia | Status unknown | TGA, au-artg | not read |
| Switzerland | Not on the register | Swissmedic, ch-swissmedic | 2026-09-03 |
| Brazil | Not on the register | ANVISA, br-anvisa | 2026-09-03 |
| Serbia | Not on the register | ALIMS, rs-alims | 2026-09-03 |
| Singapore | Not on the register | HSA, sg-hsa | 2026-09-03 |
| Turkey | Not on the register | TITCK, tr-titck | 2026-09-03 |
An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.
Side effects
Trial registerCHANGE ALERTS
Get an email when this changes
One email when the status of Cagrilintide changes on the register. You confirm your address first.
REGISTERED TRIALS
Newest 10 of 66 trials
| 2025-524249-29-00 | A placebo-controlled comparability study to compare two presentations of cagrilintide for weight management in participants with o no status recorded · register updated 2026-10-01 |
|---|---|
| NCT05567796 | A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight running, but no longer enrolling · register updated 2026-09-30 |
| NCT06323174 | A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes T completed · register updated 2026-09-30 |
| NCT07011667 | A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-t running, but no longer enrolling · register updated 2026-09-30 |
| NCT07253285 | A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight currently recruiting participants · register updated 2026-09-30 |
| NCT07564414 | A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With currently recruiting participants · register updated 2026-09-30 |
| NCT06131372 | A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesi completed · register updated 2026-09-24 |
| 2025-521384-12-00 | A research study to compare blood levels of cagrilintide after multiple doses of
different versions of cagrilintide in adults with no status recorded · register updated 2026-09-21 |
| NCT06797869 | A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic P completed · register updated 2026-09-10 |
| NCT07010432 | The Role of the Amylin Analogue Cagrilintide in Bone Metabolism currently recruiting participants · register updated 2026-09-10 |
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.